Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/49517| Title: | Balancing Efficacy and Safety With Finerenone in Patients With Heart Failure and Chronic Kidney Disease | Authors: | MARTENS, Pieter VERBRUGGE, Frederik |
Issue Date: | 2026 | Publisher: | ELSEVIER SCI LTD | Source: | Jacc-heart Failure, 14 (6) (Art N° 103063) | Notes: | Martens, P (corresponding author), Ziekenhuis Oost Limburg AV, Dept Cardiol, Synaps Pk 1, B-3600 Genk, Belgium. Pieter.martens2@zol.be |
Keywords: | chronic kidney disease;clinical trials;heart failure with preserved ejection fraction;mineralocorticoid receptor antagonist;pharmacotherapy | Document URI: | http://hdl.handle.net/1942/49517 | ISSN: | 2213-1779 | e-ISSN: | 2213-1787 | DOI: | 10.1016/j.jchf.2026.103063 | ISI #: | 001788181100001 | Rights: | 2026 by the American College of Cardiology Foundation. Published by Elsevier. | Category: | A2 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.